25 /30 territories selected thru January. Only paid on 80 targets and spiriva 1.25 taken out. Not a good sign.
Better get ready - oh wait we have great jobs.....our pipeline is the envy of the industry.....keep telling yourself that you're important and valued. Good time to apply for a diabetes overlay hugh?
The product is crap. It's been crap. It will be crap. It's been 2 years and it still sucks. Drs hate the device. Coverage is awful. When Spiriva goes generic more layoffs. It's no ones fault, except the person who decided this was the future of respiratory.
Formulary is the biggest issue. Our competitors have better formulary, 1 copay card that works for all. All my DM and long time bi counterparts do is slam the competition instead of learning from any of it. Here in NOrtheast the propaganda on spriva is that the patent is extended now we have the kid indication. And they all believe this will buy them some more time...they don't realize there is a separate asthma sales force that is contract that will be retained and will replace them all....I can't wait for all of them to run out of 1.25. What will they do then?
Coverage is not the problem. A couple main issues: -What to do with patient on ICS combo and Spiriva? -No hospital pack. Not a huge deal, but it becomes an issue at admission and discharge. -Counter detailing the device. (Come on people. Docs hated the handihaler when it came out). Also, why don't docs have issues with the CMB RMT? -Comfort with spiriva. -good managed care access (majority of the big plans) but docs also need a product they believe it.
Why did the miss the boat by not putting albuterol in the resp device? There is not generic in this class. Get a pt trained on the device early in dx and then it makes the transition easier? As a pt educator it is difficult to train pts on multiple inhalers. Keep it simple. No one likes change.
Because Combivent may as well be albuterol we could just charge $285 for it as opposed to $75 for stand alone albuterol Look at price of Striverdi - it's cheaper than CBR
STIOLTO pilot = desperation at GER HQ. Still fail to comprehend US Rx and doc behavior. ICS/LABA sample 1st, add on Spiriva for really sick patients. Chuck the patient to a specialist if still a problem. If they want to change the dynamic cut the price on formularies to beat ANORO. Otherwise stick to wurst and sauerkraut and wash it down with a Pilsner, and head off to Octoberfest. Don't worry about the silly US market behavior.
